Regulators such as the FDA do not consider aging to be a disease, and they only approve treatments for specific diseases, largely using the World Health Organization’s International Classification of Diseases as the basis for what is and is not a disease. The TAME (Targeting Aging with Metformin) trial came into being as a way ...

Read more

---

Link :
https://www.nextbigfuture.com/2024/09/multi-morbidity-as-a-definable-antiaging-target.html